D.C.’s Vanda Pharmaceuticals to ask Supreme Court to review patent infringement lawsuit


The lawsuit centers on patents for sleep drug Hetlioz, the company's biggest seller.

Previous VinFast lands deal for $1 billion share sale
Next Liberty Hospital to enter partnership with University of Kansas Health System